Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
CGM "Debate" Finds Benefits, Barriers to Uptake for Type 2 Diabetes
A light-hearted format for the discussion at the 77th Scientific Sessions of the American Diabetes Association still brought out the seriousness of the issue: too many with type 2 diabetes have poor glycemic control, and another medication may not be the answer.
CANVAS Finds Lower Risk of CV Events for Invokana
The long-awaited results from CANVAS show a reduced risk of cardiovascular events. The study's lead author said clinicians should balance the significant benefits of the drug against the potential harms for a small number of patients with known risks.
Medicare's Diabetes Prevention Program Is Coming, but CMMI Has Work to Do
No one questions the long-term savings that the Diabetes Prevention Program will bring to Medicare, but getting it off the ground will require several steps that have never been done before, including a new payment model.
UnitedHealthcare to Cover At-Home Colon Cancer Screening Kit
With the nation's largest commercial payer on board, the maker of the at-home DNA colon cancer screening test will put more focus on physician education and consumer awareness, with the hope of increasing screening rates for a test that patients find uncomfortable and inconvenient.
Study Finds Increased PCSK9 in Youth With Type 1 Diabetes
The enzyme that affects the body's ability to process LDL cholesterol was found to be correlated with A1C levels. A symposium on the topic will be part of this weekend's 77th Scientific Sessions of the American Diabetes Association.
JDRF Urges Payers to Allow Choice, Limit Out-of-Pocket Costs, Cover Technology
The #Coverage2Control campaign begins a year after the announcement that UnitedHealth would shift most adult type 1 diabetes patients toward Medtronic technology, or require them to pay significant out-of-pocket costs. More significantly, JDRF reports payers are saying they will not fund the artificial pancreas.
Childhood Obesity Raises Risk of Arterial Damage in Adulthood, Study Finds
Researchers from the United Kingdom combed studies to figure out which of several indicators, such as body mass index or waist circumference, were predictors of future cardiac events or health conditions, like hypertension or prediabetes.
Americans Over 40 Think Medicare Should Pay for Long-Term Care
Few people have adequate savings for long-term care, and most assume they will care for relatives and rely on family for their own care. A survey from the Associated Press and the NORC Center for Public Affairs Research found support for family leave policies across members of both parties.
CBO Finds House Healthcare Bill Saves $119 Billion, Would Cause 23 Million to Lose Coverage
A Senate working group is already crafting an entirely new version of a replacement for the Affordable Care Act. House Speaker Paul Ryan waited on a new CBO score to make sure the American Health Care Act met necessary savings targets to use the budget reconciliation process to undo Obamacare.
Endocrine Society Protests Cuts to NIH, CDC; Says Diabetes Prevention Program Would Be Curtailed
The proposed cuts would come just as CMS is gearing up to launch the Diabetes Prevention Program in Medicare starting in January 2018. Diabetes accounts for $1 of every $3 spent in Medicare, and CMS has been looking for ways to slow the number of beneficiaries who develop the disease.
CGM Offers Confidence Boost for Those Managing Diabetes With Insulin Injections, Study Finds
The researchers' hypothesis: improvements in continuous glucose monitoring technology would bring greater quality of life improvements for those with type 1 diabetes, even if they were not using insulin pumps.